Glycomine (Series C)

Funding Details
Awarder
Inbox
Date Award
April 16, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
Glycomine is a biotechnology company focused on developing transformative new therapies for orphan diseases.
Market
Orphan diseases
Location
San Carlos, California, USA
Coinvestors
CTI Life Sciences Fund, abrdn Inc., Advent Life Sciences, Novo Holdings, Sanofi Ventures, Abingworth, RiverVest Venture Partners, Sanderling Ventures, Chiesi Ventures, Remiges Ventures, Asahi Kasei Ventures

Links
Back to Home Back to Biotechnology Deals View Funding Announcement